Chevy Chase Trust
ARKG icon

Chevy Chase Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Chevy Chase Trust’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-122,216
Closed -$3.45M – 637
2022
Q4 		$3.45M Buy
+122,216
New +$3.88M 0.01% 531
2019
Q1 		– Sell
-34,299
Closed -$822K – 659
2018
Q4 		$822K Buy
+34,299
New +$966K ﹤0.01% 580

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Chevy Chase Trust's ARKG Position: Q1 2023 in Review

Chevy Chase Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 122,216 shares — an estimated $3.45M sold.

Chevy Chase Trust first reported a position in ARKG in Q4 2018 and held it in 2 quarters. The position peaked at $3.45M in Q4 2022. 296 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Chevy Chase Trust reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Chevy Chase Trust sold 122,216 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $3.45M.
  • Chevy Chase Trust first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 2 quarters.
  • Chevy Chase Trust's ARK Genomic Revolution ETF position peaked at $3.45M in Q4 2022.
  • 296 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Chevy Chase Trust's 13F filing for Q1 2023, filed 16 May 2023.